Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Liu, Jinxia ^a   Cheng, Xin ^a   Guo, Zhengrong ^a   Wang, Zihua ^a   Li, Dong ^a   Kang, Fubiao ^a   Li, Haijun ^a   Li, Baosheng ^a   Cao, Zhichen ^b   Nassal, Michael ^c   Sun, Dianxing ^a  

^a BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; MESSENGER RNA; NEUTROPHIL COLLAGENASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; GENE; GENE EXPRESSION; HEPATITIS B VIRUS; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; MATRIX METALLOPROTEINASE 8 GENE; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; RAT; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY; VIRION; VIRUS PARTICLE; VIRUS REPLICATION; WILD TYPE;

ADENOVIRIDAE; ANIMALS; CELL PROLIFERATION; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROSIS; GENETIC THERAPY; GENETIC VECTORS; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; LIVER; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 8; MICROSCOPY, FLUORESCENCE; RATS; TRANSFECTION;

ADENOVIRIDAE; HEPATITIS B VIRUS; RATTUS;

EID: 84871855596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053392     Document Type: Article

References (67)

1. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, et al. (1978) The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 31: 395-414.
2. Ellis EL, Mann DA, (2012) Clinical evidence for the regression of liver fibrosis. J Hepatol 56: 1171-1180.
3. Forner A, Llovet JM, Bruix J, (2012) Hepatocellular carcinoma. Lancet 379: 1245-1255.
4. Goyal N, Jain N, Rachapalli V, Cochlin DL, Robinson M, (2009) Non-invasive evaluation of liver cirrhosis using ultrasound. Clin Radiol 64: 1056-1066.
5. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M, (2010) Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology 51: 1445-1449.
6. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP, (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45: 529-538.
7. Mormone E, George J, Nieto N, (2011) Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact 193: 225-231.
8. Friedman SL, (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
9. Gressner AM, (1991) Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem 29: 293-311.
10. Rojkind M, Giambrone MA, Biempica L, (1979) Collagen types in normal and cirrhotic liver. Gastroenterology 76: 710-719.
11. Schuppan D, (1990) Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 10: 1-10.
12. Montfort I, Perez-Tamayo R, (1978) Collagenase in experimental carbon tetrachloride cirrhosis of the liver. Am J Pathol 92: 411-420.
13. Perez-Tamayo R, Montfort I, Gonzalez E, (1987) Collagenolytic activity in experimental cirrhosis of the liver. Exp Mol Pathol 47: 300-308.
14. Nagase H, Visse R, Murphy G, (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
15. Page-McCaw A, Ewald AJ, Werb Z, (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233.
16. Hemmann S, Graf J, Roderfeld M, Roeb E, (2007) Expression of MMPs and TIMPs in liver fibrosis- a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46: 955-975.
17. Moore CS, Crocker SJ, (2012) An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 180: 12-16.
18. Iimuro Y, Brenner DA, (2008) Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res 25: 249-258.
19. Iredale JP, (2004) A cut above the rest? MMP-8 and liver fibrosis gene therapy. Gastroenterology 126: 1199-1201.
20. Tsukamoto H, Matsuoka M, French SW, (1990) Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10: 56-65.
21. Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic B, et al. (2003) Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 124: 445-458.
22. Siller-Lopez F, Sandoval A, Salgado S, Salazar A, Bueno M, et al. (2004) Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 126: 1122-1133; discussion 1949.
23. Descamps D, Benihoud K, (2009) Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction. Curr Gene Ther 9: 115-127.
24. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409.
25. Ni S, Bernt K, Gaggar A, Li ZY, Kiem HP, et al. (2005) Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. Hum Gene Ther 16: 664-677.
26. Beck J, Nassal M, (2007) Hepatitis B virus replication. World J Gastroenterol 13: 48-64.
27. Nassal M, (2008) Hepatitis B viruses: reverse transcription a different way. Virus Res 134: 235-249.
28. Protzer U, Nassal M, Chiang PW, Kirschfink M, Schaller H, (1999) Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci U S A 96: 10818-10823.
29. Raney AK, Milich DR, Easton AJ, McLachlan A, (1990) Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol 64: 2360-2368.
30. Junker-Niepmann M, Bartenschlager R, Schaller H, (1990) A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J 9: 3389-3396.
31. Ganem D, (1999) An advance in liver-specific gene delivery. Proc Natl Acad Sci U S A 96: 11696-11697.
32. Walters KA, Joyce MA, Addison WR, Fischer KP, Tyrrell DL, (2004) Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen. J Virol 78: 7925-7937.
33. Siller-López F, Sandoval A, Salgado S, Salazar A, Bueno M, et al. (2004) Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 126: 1122-1133.
34. Untergasser A, Protzer U, (2004) Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters. Hum Gene Ther 15: 203-210.
35. Siller-Lopez F, Garcia-Banuelos J, Hasty KA, Segura J, Ramos-Marquez M, et al. (2000) Truncated active matrix metalloproteinase-8 gene expression in HepG2 cells is active against native type I collagen. J Hepatol 33: 758-763.
36. Ren S, Nassal M, (2001) Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J Virol 75: 1104-1116.
37. Sprinzl MF, Oberwinkler H, Schaller H, Protzer U, (2001) Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol 75: 5108-5118.
38. Iredale JP, (2004) A cut above the rest? MMP-8 and liver fibrosis gene therapy. Gastroenterology 126: 1199-1201.
39. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
40. Nassal M, (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66: 4107-4116.
41. Liu JX, Sun DX, Cao ZC, (2009) [Stable cell line for secretion of replication-defective hepatitis B virus vector expressing blasticidin resistant gene]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23: 316-318.
42. Pelman GR, Morrison CJ, Overall CM, (2005) Pivotal Molecular Determinants of Peptidic and Collagen Triple Helicase Activities Reside in the S3' Subsite of Matrix Metalloproteinase 8 (MMP-8): The role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond. Journal of Biological Chemistry 280: 2370-2377.
43. Li D, Liu J, Kang F, Guan W, Gao X, et al. (2011) Core-APOBEC3C chimerical protein inhibits hepatitis B virus replication. J Biochem 150: 371-374.
44. Sun D, Nassal M, (2006) Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45: 636-645.
45. Sun D, Rosler C, Kidd-Ljunggren K, Nassal M, (2010) Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites. J Hepatol 52: 817-826.
46. Bruck R, Weiss S, Traister A, Zvibel I, Aeed H, et al. (2007) Induced hypothyroidism accelerates the regression of liver fibrosis in rats. Journal of gastroenterology and hepatology 22: 2189-2194.
47. Rojkind M, Gonz̈¢lez E, (1974) An improved method for determining specific radioactivities of proline-14C and hydroxyproline-14C in collagen and in noncollagenous proteins. Analytical Biochemistry 57: 1-7.
48. Junqueira LC, Bignolas G, Brentani RR, (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455.
49. Wang TL, Liu X, Zhou YP, (1998) A semiquantitative scoring system for assessment of hepatic inflammation and fibrosis in chronic viral hepatitis. Chinese Journal of Hepatology 6: 195-197.
50. Schaller H, Fischer M, (1991) Transcriptional control of hepadnavirus gene expression. Curr Top Microbiol Immunol 168: 21-39.
51. Hildt E, Hofschneider PH, (1998) The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res 154: 315-329.
52. Bartenschlager R, Junker-Niepmann M, Schaller H, (1990) The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 64: 5324-5332.
53. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, et al. (2010) Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 67: 677-700.
54. Schulze A, Mills K, Weiss TS, Urban S, (2012) Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55: 373-383.
55. Hantz O, Parent R, Durantel D, Gripon P, Guguen-Guillouzo C, et al. (2009) Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol 90: 127-135.
56. Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, et al. (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55: 996-1003.
57. Guo H, Xu C, Zhou T, Block TM, Guo JT, (2012) Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formation. PLoS One 7: e43270.
58. Oren R, Dotan I, Papa M, Marravi Y, Aeed H, et al. (1996) Inhibition of experimentally induced cirrhosis in rats by hypothyroidism. Hepatology 24: 419-423.
59. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-435.
60. Gherardi E, Birchmeier W, Birchmeier C, Vande Woude G, (2012) Targeting MET in cancer: rationale and progress. Nat Rev Cancer 12: 89-103.
61. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, et al. (2004) Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A 101: 10608-10613.
62. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, et al. (2004) Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A 101: 4477-4482.
63. Paranjpe S, Bowen WC, Bell AW, Nejak-Bowen K, Luo JH, et al. (2007) Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology 45: 1471-1477.
64. Zoulim F, Durantel D, Deny P, (2009) Management and prevention of drug resistance in chronic hepatitis B. Liver Int. 29Suppl 1: 108-115.
65. Hildt E, Saher G, Bruss V, Hofschneider PH, (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225: 235-239.
66. Hildt E, Urban S, Hofschneider PH, (1995) Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene 11: 2055-2066.
67. Dandri M, Burda MR, Zuckerman DM, Wursthorn K, Matschl U, et al. (2005) Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J Hepatol 42: 54-60.